BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 28, 2003
View Archived Issues
Stock Winners and Losers For The Week
Read More
Biotechnology Company Deals With Other Biotechnology Companies: Collaborations, Agreements, Equity Participation, Feb. 20 - April 23, 2003
Read More
Biotechnology Company Deals With Miscellaneous Companies: Collaborations, Agreements, Equity Participation, Feb. 20 - April 23, 2003
Read More
Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Feb. 20 - April 23, 2003
Read More
Biotech - Biotech Collaborations: Modified And Terminated Agreements, Feb. 20 - April 23, 2003
Read More
BioWorld Stock Report For Public Biotechnology Companies
Read More
Psoriasis Survey Finds Market Robust, Room For Many Winners
Familiarity may breed contempt in some settings, but in the prescription world it often means a leg up on competing drugs. Such appears to be the case with Enbrel (etanercept), Amgen Inc.'s rheumatoid arthritis treatment approved in 1998.
Read More
Money Raised Year To Date
Read More